MICHELLE SELF: Open Payments
NPI 1669086377 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 16 payments from 7 companies in 2025. Trend: 2023 $454 · 2024 $213 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $102 |
| Exeltis, USA Inc. | 4 | $79 |
| Baxter Healthcare | 1 | $38 |
| MILLICENT US INC | 2 | $37 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
| Organon LLC | 1 | $18 |
| Integra LifeSciences Corporation | 1 | $16 |
Products named: MYFEMBREE, SLYND, TISSEEL, INTRAROSA, JOURNAVX, GEMTESA, NEXPLANON, OMNIGRAFT.
Industry payments across TX — which companies pay providers there.
